rs768711283
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. PP2BS1_SupportingBS2
The NM_001035.3(RYR2):c.11497G>A(p.Asp3833Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000373 in 1,553,506 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. D3833D) has been classified as Likely benign.
Frequency
Consequence
NM_001035.3 missense
Scores
Clinical Significance
Conservation
Publications
- arrhythmogenic right ventricular dysplasia 2Inheritance: AD Classification: DEFINITIVE, NO_KNOWN Submitted by: Laboratory for Molecular Medicine, Ambry Genetics
- catecholaminergic polymorphic ventricular tachycardiaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P
- catecholaminergic polymorphic ventricular tachycardia 1Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- hypertrophic cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RYR2 | ENST00000366574.7 | c.11497G>A | p.Asp3833Asn | missense_variant | Exon 85 of 105 | 1 | NM_001035.3 | ENSP00000355533.2 | ||
| RYR2 | ENST00000661330.2 | c.11521G>A | p.Asp3841Asn | missense_variant | Exon 86 of 106 | ENSP00000499393.2 | ||||
| RYR2 | ENST00000609119.2 | n.*2589G>A | non_coding_transcript_exon_variant | Exon 84 of 104 | 5 | ENSP00000499659.2 | ||||
| RYR2 | ENST00000609119.2 | n.*2589G>A | 3_prime_UTR_variant | Exon 84 of 104 | 5 | ENSP00000499659.2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152102Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000426 AC: 7AN: 164282 AF XY: 0.0000231 show subpopulations
GnomAD4 exome AF: 0.0000385 AC: 54AN: 1401404Hom.: 0 Cov.: 29 AF XY: 0.0000318 AC XY: 22AN XY: 691606 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152102Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74292 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Catecholaminergic polymorphic ventricular tachycardia 1 Uncertain:2
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 3833 of the RYR2 protein (p.Asp3833Asn). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with clinical features of RYR2-related conditions (PMID: 26743238, 30615648, 32152366). ClinVar contains an entry for this variant (Variation ID: 201312). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt RYR2 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
Variant summary: RYR2 c.11497G>A (p.Asp3833Asn) results in a conservative amino acid change located in the RyR/IP3R Homology associated domain (IPR013662) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4.3e-05 in 164282 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.11497G>A has been reported in the literature in individuals affected with Catecholaminergic Polymorphic Ventricular Tachycardia (Adler_2016, Olubando_2020), hypertrophic cardiomyopathy (Mademont-Soler_2017), and stillbirth (Sahlin_2019) with conflicting interpretations of pathogenicity. These report(s) do not provide unequivocal conclusions about association of the variant with Catecholaminergic Polymorphic Ventricular Tachycardia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four ClinVar submitters have submitted clinical-significance assessments for this variant to ClinVar after 2014. All laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Catecholaminergic polymorphic ventricular tachycardia Uncertain:1
This missense variant replaces aspartic acid with asparagine at codon 3833 of the RYR2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with hypertrophic cardiomyopathy who also carried a pathogenic variant in the MYBPC3 gene (PMID: 28771489). This variant has also been observed in an individual suspected of having inherited arrhythmia disease (PMID: 26743238) and in a stillbirth (PMID: 30615648). This variant has been identified in 9/195672 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Cardiomyopathy Uncertain:1
This missense variant replaces aspartic acid with asparagine at codon 3833 of the RYR2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with hypertrophic cardiomyopathy who also carried a pathogenic variant in the MYBPC3 gene (PMID: 28771489). This variant has also been observed in an individual suspected of having inherited arrhythmia disease (PMID: 26743238) and in a stillbirth (PMID: 30615648). This variant has been identified in 9/195672 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Identified independently and in conjunction with additional cardiogenetic variants in individuals in published literature but segregation data are limited or absent at this time (Adler et al., 2016; Sahlin et al., 2019; Mademont-Soler et al., 2017); This variant is associated with the following publications: (PMID: 19926015, 26743238, 30615648, 28771489) -
Arrhythmogenic right ventricular dysplasia 2 Uncertain:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Cardiovascular phenotype Uncertain:1
The p.D3833N variant (also known as c.11497G>A), located in coding exon 85 of the RYR2 gene, results from a G to A substitution at nucleotide position 11497. The aspartic acid at codon 3833 is replaced by asparagine, an amino acid with highly similar properties. This alteration has been reported in an inherited arrhythmia cohort, a hypertrophic cardiomyopathy (HCM) cohort and a stillbirth cohort (Adler A et al. Circ Arrhythm Electrophysiol, 2016 Jan;9:e003440; Mademont-Soler I et al. PLoS One, 2017 Aug;12:e0181465; Sahlin E et al. PLoS One, 2019 Jan;14:e0210017). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at